High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
If a budget falls apart, identify the breach, stop further spirals, and implement a simple recovery plan to restore stability.
16,942 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
A top executive leaves Bitcoin Depot as regulators tighten the screws on crypto kiosks. The move highlights how the c...
Geopolitics just accelerated volatility in energy markets. The rejection of a ceasefire proposal by iran has traders ...
As Warren Buffett's successor, Greg Abel has begun steering Berkshire Hathaway's portfolio with careful turns. A nota...
First Advantage stock is climbing today as investors react to better-than-expected results and a growing AI-focused d...
Nvidia and Alphabet are leading a new era of high-growth tech. This deep dive breaks down why each company could reac...
Astronics reports a mixed Q1 2026 that tests the durability of its backlog and margin recovery. This article breaks d...
Self-employed workers who filed paper returns in the 1990s may have missing earnings data, risking tens of thousands ...
Investor sentiment shifted on a day when Poet Technologies announced a large equity offering. This piece explains wha...
As AI workloads surge, choosing the right infrastructure partner matters. This guide compares CoreWeave and Nebius, w...
A shift in AI hardware could redefine winners and losers in tech investing. Here’s how ASICs may outpace GPUs and whi...
As investors seek durable AI upside beyond chips, three ETFs focusing on the software layer beat peers and promise re...